NeoGenomics, Inc. (NEO)
NeoGenomics Market Cap: 1.707B for Jan. 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| IQVIA Holdings, Inc. | 41.10B |
| Incyte Corp. | 20.80B |
| Regeneron Pharmaceuticals, Inc. | 79.26B |
| Arcturus Therapeutics Holdings, Inc. | 219.63M |
| Fortrea Holdings, Inc. | 1.550B |
Market Cap Related Metrics
| PS Ratio | 2.377 |
| PEG Ratio | -0.3357 |
| Price to Book Value | 2.037 |
| Price | 13.20 |
| Earnings Yield | -6.73% |
| PEGY Ratio | -0.3357 |